Literature DB >> 23732671

[Expression of Myogenin and MCK genes regulated by PI3K/AKT pathway].

Jing Li1, Yun-Sheng Zhang, Ning Li, Xiao-Xiang Hu, Guo-Qing Shi, Shou-Ren Liu, Nan Liu.   

Abstract

Many intracellular signaling pathways regulate skeletal muscle differentiation. Among them, PI3K/AKT pathway plays an important role. But the mechanisms of chromatin regulation remain unclear. In this study, the murine C2C12 myoblast cell line was used to investigate the expression of Myogenin and MCK genes during the skeletal muscle differentiation. Western blotting analysis showed that the expression of Myogenin and MCK protein was increased significantly after PI3K/AKT activator treatment for 24 h during the C2C12 cell differentiation and the expression of H3K27me3 demethylase UTX was also increased. Chromatin immunoprecipitation (ChIP) and quantitative PCR (Q-PCR) analysis showed that the enrichment of H3K27me3 on the promoter regions of Myogenin and MCK genes and the enhancer region of MCK gene were decreased. It was opposite to the PI3K/AKT inhibitor treatment. We concluded that the PI3K/AKT pathway maybe regulate skeletal muscle differentiation by regulating the expression of UTX gene to change the enrichment of H3K27me3 on the target genes.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23732671     DOI: 10.3724/sp.j.1005.2013.00637

Source DB:  PubMed          Journal:  Yi Chuan        ISSN: 0253-9772


  2 in total

1.  Activated Integrin-Linked Kinase Negatively Regulates Muscle Cell Enhancement Factor 2C in C2C12 Cells.

Authors:  Zhenguo Dong; Wei Pan; Haiqing Wu; Dongjun Liu; Ming Cang
Journal:  Biomed Res Int       Date:  2015-12-16       Impact factor: 3.411

2.  VEGFB Promotes Myoblasts Proliferation and Differentiation through VEGFR1-PI3K/Akt Signaling Pathway.

Authors:  Mingfa Ling; Lulu Quan; Xumin Lai; Limin Lang; Fan Li; Xiaohua Yang; Yiming Fu; Shengchun Feng; Xin Yi; Canjun Zhu; Ping Gao; Xiaotong Zhu; Lina Wang; Gang Shu; Qingyan Jiang; Songbo Wang
Journal:  Int J Mol Sci       Date:  2021-12-12       Impact factor: 5.923

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.